What You Should Know:
- DreaMed Diabetes AI, developer of the AI-powered Advisor Pro Clinical Decision Support System and expert-care platform for diabetes, announced today the expansion of its commercial relationship with the Pediatric Endocrinology Clinic at the University of Florida in Gainesville.
- The clinic will begin using the Advisor Pro Decision-Support System for people with Type 2 and Type 1 diabetes, enhancing its offering to healthcare practitioners and patients.
- Advisor
Read More
DreaMed Diabetes
Yale New Haven Health Deploys Virtual Clinic for Pediatric Patients with Diabetes
What You Should Know:
- After taking part in proving the clinical benefit of using AI-based decision support tools, as was recently published in Nature Medicine, Yale New Haven Health System and DreaMed Diabetes announced a collaboration that will explore what it would take to adopt such a solution into a real-world health system.
- As part of the collaboration, Yale New Haven will utilize DreaMed’s Advisor Pro platform to create a virtual clinic, this real-world evaluation will assess the
Read More
Data-Driven Future: Impact of Machine Learning on Diabetes Management
“Information technology and business are becoming inextricably interwoven. I don't think anybody can talk meaningfully about one without the talking about the other” – Bill Gates wrote this in 1999 and, nowadays, the same can certainly be said about information technology and healthcare.
The ability to collect, analyze, and use data is becoming ubiquitous with many of healthcare’s most exciting advancements. Whether it’s Google’s DeepMind using artificial intelligence (AI) to help
Read More
Why Remote Medical Solutions Are More Than Just A Pandemic Response
The health industry has increasingly emphasized convenience these past few decades, with methods developed to seamlessly integrate health management into our daily routines. Gone are the days in which people needed an entire day off just to see the doctor. This same focus has taken on extra meaning as of late, with the pandemic creating a need for treatment options that work around the constraints of social distancing. As a result, a host of digital-based solutions began appearing, providing
Read More
DreaMed Diabetes Supports Research on Efficacy of Virtual Diabetes Care
What You Should Know:
- DreaMed Diabetes, the developer of personalized, AI-based diabetes management solutions, will participate in a clinical study, led by Jaeb Center for Health Research Foundation, to evaluate the efficacy of virtual treatment for diabetes patients. The research is funded by a grant from The Leona M. and Harry B. Helmsley Charitable Trust.
- DreaMed uses AI-powered technology to seamlessly treat
patients remotely with its virtual diabetes management service by
Read More
DreaMed Launches Virtual Diabetes Clinic to Help Type-1 Diabetics Control Their Condition in Quarantine
What You Should Know:
- As COVID-19 spreads, DreaMed Diabetes unveils virtual diabetes clinic software to treat people with type 1 diabetes remotely.
- The virtual clinic utilizes Dreamed Diabetes’ AI-powered solution, to improve the insulin management treatment by analyzing the patient’s insulin and glucose data in the platform's algorithm and to remotely advise doctors on treatment.
- According to the CDC people with chronic medical conditions, including diabetes, have a higher risk
Read More
Why Hospitals Are the Ideal “Garage” for MedTech Startups
In 1796, when smallpox was truly a world epidemic, Dr. Edward Jenner inoculated his gardener’s son with a vaccine derived from another patient’s cowpox blister. At the time, the disease was killing 10 percent of the population. While other treatments for smallpox existed, it was Jenner’s that could be easily replicated around the world. And in hindsight, we know that a key factor in Jenner’s development of the vaccine was his access to patients, his scientific knowledge and his passion to heal.
Read More
DreaMed Diabetes Granted FDA Approval for Personalized Diabetes Decision Support Solution
DreaMed Diabetes, an Israeli-based developer of personalized diabetes management solutions, today announced that the U.S Food and Drug Administration (FDA) has granted a De Novo request for DreaMed Advisor Pro, an artificial intelligence (AI)-based diabetes treatment decision support software. Advisor Pro is indicated to assist healthcare providers in the management of people with type 1 diabetes who use insulin pumps and continuous glucose monitoring (CGM).The announcement marks the second
Read More
